AZ buys Ionis’ NASH candidate

10th April 2018 Uncategorised 0

AstraZeneca has bought rights to an experimental antisense therapy from Ionis Pharmaceuticals, in a deal that could be worth more than $300 million

More: AZ buys Ionis’ NASH candidate
Source: News